Strategic Report on Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market: Growth Opportunities and Emerging Challenges
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What CAGR Is Anticipated for the Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Through 2029?
The market size for contract development and manufacturing organizations (CMO) in the pharmaceutical sector has been demonstrating robust growth in the recent past. The market is projected to expand from $174.33 billion in 2024 to $184.39 billion in 2025, registering a compound annual growth rate (CAGR) of 5.8%. The notable expansion during the historical period can be credited to the significant economic progression in the emerging markets, growth in healthcare spending, escalation in pharmaceutical research and development (R&D) investment, and a growing inclination towards outsourcing.
The market size of the pharmaceutical contract development and manufacturing organization, or CMO, is forecasted to experience substantial expansion over the next several years. As predictions suggest, it is set to escalate to “$255.58 billion in 2029“, growing at a compound annual growth rate (CAGR) of 8.5%. Several factors are contributing to this uptick during the projected period including enhanced government backing, improved access to healthcare, rising investments, and the growth of biopharmaceutical development. Key trends for this period encompass a heightened emphasis on sustainability, the incorporation of artificial intelligence and digitization, the roll-out of innovative products that emphasize resilience, and the increase in investment as well as strategic partnerships and cooperative initiatives amongst market players.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2825&type=smp
What Market Forces Are Driving The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Sector In 2025 And Beyond?
The expansion of the pharmaceutical contract development and manufacturing market is fueled by the rising global demand for medications. The broad prevalence of diseases and the desire for a longer lifespan has heightened the requirement for medications, compelling pharmaceutical manufacturers to boost the production of existing drugs and escalate investment in research and development for new drug exploration. This compels these firms to partner with contract manufacturing organizations (CMOs), as a strategy to reduce operational expenditures, subsequently increasing the need for pharmaceutical contract development and manufacturing market. Based on information from Alkermes PLC., a biopharmaceutical firm, pharmaceutical contract manufacturing is likely to become a strategic choice for a variety of companies, from large-scale to smaller niche pharmaceutical entities, principally due to pharmaceutical companies’ pursuit of cost reduction.
The pharmaceutical contract development and manufacturing organization (cmo) market covered in this report is segmented –
1) By Type: Contract Manufacturing Services, Contract Research Services
2) By Research Phase: Preclinical, Phase I, Phase II, Phase III, Phase IV
2) By End User: Big Pharmaceutical Companies, Generic Pharmaceutical Companies, Small And Medium-Sized Pharmaceutical Companies
Subsegments:
1) By Contract Manufacturing Services: Active Pharmaceutical Ingredient (API) Manufacturing, Formulation Development, Finished Dosage Form Manufacturing, Packaging Services, Supply Chain Management
2) By Contract Research Services: Preclinical Research Services, Clinical Trial Management, Regulatory Affairs Consulting, Biostatistics And Data Management, Analytical And Testing Services
What Are The Leading Trends And Opportunities In The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Sector?
Companies operating in the pharmaceutical contract development and manufacturing market are focusing on acquisitions and partnerships with other participants in the landscape. This move aligns with the prevalent trend of mergers and acquisitions among pharmaceutical contract development and manufacturing firms, aiming to extend their international market presence, fulfill customer requirements, enhance production competencies while ensuring cost-effectiveness, and tap into advanced technology and novel services. This surge in merger and acquisition activities leads to the unification of contract service providers. For example, in July 2022, Pharma Nobis, a US company offering contract manufacturing and private label services, secured Fagron’s U.S. contract manufacturing business for a not disclosed figure. This deal allows Pharma Nobis to extend its contract manufacturing and private label services to American retailers and consumer healthcare corporations. Fagron will retain 20% ownership in the company.
Which Firms Are Considered Leaders In The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Space?
Major companies operating in the pharmaceutical contract development and manufacturing organization (CMO) market include Lonza Group, Catalent Inc, WuXi AppTec Inc., Pfizer Inc, Recipharm AB, Almac Group, Aenova Group, Baxter International Inc, SGS Life Science Services SA, Jubilant Pharmova Ltd, Dishman Pharmaceuticals, Kemwell Pvt. Ltd., Nipro Corp., CMIC Group, Sawai Pharmaceutical Co., Ltd, IDT Australia Limited, Aurigene Pharmaceutical Services Limited, Vetter Pharma International GMBH, Consort Medical PLC, Siegfried Holding AG, Evonik Industries, NextPharma, Royal DSM N.V, HAUPT Pharma AG, Boehringer Ingelheim International GmbH, Famar, OTC-PharmNEUCA, Farmacol, Polska Grupa Farmaceutyczna, Polpharma, TZMO, AbbVie Inc, Merck & Co Inc, Amgen Inc, Gilead Sciences Inc, Regeneron Pharmaceuticals Inc, Vertex Pharmaceuticals Inc, Johnson & Johnson, Eurofarma Laboratórios S.A., Ache Laboratórios Farmacêuticos S.A., Blanver Farmoquímica e Farmacêutica S.A., Prati-Donaduzzi, União Química Farmacêutica Nacional S.A, Laboratorios Richmond S.A.C.I.F., Bago S.A., Elea Laboratories S.A.C.I. y F., Gador S.A., LIFEPharma, Neopharm, Gulf Pharmaceutical Industries JULPHA, NewBridge Pharmaceuticals Limited, Aspen Pharmacare Holdings Limited, Adcock Ingram Holdings Limited, Pharma-Q (Pty) Ltd, Vital Health Foods, EIPICO (Egyptian International Pharmaceutical Industries Company), Pharco Pharmaceuticals
What Role Do Regional Policies And Investments Play In Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Expansion?
North America was the largest region in the global pharmaceutical contract development and manufacturing market in 2024. The Middle East is expected to be the fastest-growing region in the global pharmaceutical contract development and manufacturing market during the forecast period. The regions covered in the pharmaceutical contract development and manufacturing organization (cmo) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=2825&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
